Why Sumita chose to try the injectable Manjaro

The Trump administration is making GLP-1s more affordable. This class of drugs seems to have forever changed the game on diet and exercise for Americans.

This episode was produced by Miles Bryan, edited by Jolie Myers, fact-checked by Laura Bullard, engineered by Patrick Boyd and Andrea Kristinsdottir, and hosted by Noel King.

A pharmacist holds a box of Ozempic brand semaglutide medication. Photo by George Frey/Bloomberg via Getty Images.

Listen to Today, Explained ad-free by becoming a Vox Member: vox.com/members. New Vox members get $20 off their membership right now. Transcript at ⁠vox.com/today-explained-podcast.⁠

Learn more about your ad choices. Visit podcastchoices.com/adchoices